Your browser doesn't support javascript.
loading
Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors.
Kim, TaeWon; Havighurst, Thomas; Kim, KyungMann; Albertini, Mark; Xu, Yaohui G; Spiegelman, Vladimir S.
Afiliación
  • Kim T; Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Havighurst T; Molecular and Environmental Toxicology Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Kim K; Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Albertini M; Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Xu YG; Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Spiegelman VS; Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Mol Carcinog ; 57(5): 678-683, 2018 05.
Article en En | MEDLINE | ID: mdl-29369405
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas de Unión al ARN / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Vemurafenib / Melanoma Límite: Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas de Unión al ARN / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Vemurafenib / Melanoma Límite: Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2018 Tipo del documento: Article